These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904 [TBL] [Abstract][Full Text] [Related]
23. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study. Polgár C; Major T; Fodor J; Németh G; Orosz Z; Sulyok Z; Udvarhelyi N; Somogyi A; Takácsi-Nagy Z; Lövey K; Agoston P; Kásler M Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1173-81. PubMed ID: 15519789 [TBL] [Abstract][Full Text] [Related]
24. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study. Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448 [TBL] [Abstract][Full Text] [Related]
25. Reirradiation of locally recurrent nasopharyngeal carcinoma. Lengyel E; Baricza K; Somogyi A; Olajos J; Pápai Z; Godény M; Németh G; Esik O Strahlenther Onkol; 2003 May; 179(5):298-305. PubMed ID: 12740656 [TBL] [Abstract][Full Text] [Related]
27. Quality of interstitial PDR-brachytherapy-implants of head-and-neck-cancers: predictive factors for local control and late toxicity? Melzner WJ; Lotter M; Sauer R; Strnad V Radiother Oncol; 2007 Feb; 82(2):167-73. PubMed ID: 17258340 [TBL] [Abstract][Full Text] [Related]
28. Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer. Hsu IC; Cabrera AR; Weinberg V; Speight J; Gottschalk AR; Roach M; Shinohara K Brachytherapy; 2005; 4(3):202-6. PubMed ID: 16182220 [TBL] [Abstract][Full Text] [Related]
29. Feasibility of combined operation and perioperative intensity-modulated brachytherapy of advanced/recurrent malignancies involving the skull base. Strege RJ; Kovács G; Maune S; Holland D; Niehoff P; Eichmann T; Mehdorn HM Strahlenther Onkol; 2005 Feb; 181(2):97-107. PubMed ID: 15702298 [TBL] [Abstract][Full Text] [Related]
30. Radical radiotherapy compared with surgery for advanced squamous cell carcinoma of the base of tongue. van de Pol M; Levendag PC; de Bree RR; Franssen JH; Smeele LE; Nijdam WM; Jansen PP; Meeuwis CA; Leemans CR Brachytherapy; 2004; 3(2):78-86. PubMed ID: 15374539 [TBL] [Abstract][Full Text] [Related]
31. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)]. Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148 [TBL] [Abstract][Full Text] [Related]
32. High-dose-rate interstitial brachytherapy for oropharyngeal carcinoma: results of 83 lesions in 82 patients. Nose T; Koizumi M; Nishiyama K Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):983-91. PubMed ID: 15234031 [TBL] [Abstract][Full Text] [Related]
33. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience. Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997 [TBL] [Abstract][Full Text] [Related]
34. Treatment of T1-T2 rectal tumors by contact therapy and interstitial brachytherapy. Coatmeur O; Truc G; Barillot I; Horiot JC; Maingon P Radiother Oncol; 2004 Feb; 70(2):177-82. PubMed ID: 15028405 [TBL] [Abstract][Full Text] [Related]
36. [Retrospective study of 136 cases of epidermoid carcinoma of the base of the tongue treated at the Alexis Vautrin Centre 1978-1992]. Hoffstetter S; Malissard L; Pernot M; Luporsi E; Peiffert D; Lapeyre M Bull Cancer Radiother; 1996; 83(2):90-6. PubMed ID: 8688225 [TBL] [Abstract][Full Text] [Related]
37. [Interstitial and percutaneous radiotherapy after limited surgery in carcinoma of the oral cavity]. Fietkau R; Grabenbauer GG; Iro H; Müller RG; Farmand M; Atendorf-Hofmann A; Sauer R Strahlenther Onkol; 1991 Oct; 167(10):591-8. PubMed ID: 1948644 [TBL] [Abstract][Full Text] [Related]
38. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer. Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473 [TBL] [Abstract][Full Text] [Related]
39. Exclusive low-dose-rate brachytherapy in 279 patients with T2N0 mobile tongue carcinoma. Bourgier C; Coche-Déquéant B; Fournier C; Castelain B; Prévost B; Lefebvre JL; Lartigau E Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):434-40. PubMed ID: 16168836 [TBL] [Abstract][Full Text] [Related]
40. Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy. Ortholan C; Ramaioli A; Peiffert D; Lusinchi A; Romestaing P; Chauveinc L; Touboul E; Peignaux K; Bruna A; de La Roche G; Lagrange JL; Alzieu C; Gerard JP Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):479-85. PubMed ID: 15890590 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]